NCT01714960View on ClinicalTrials.gov

Safety and Tolerability of MRZ-99030 Eye Drops in Healthy Volunteers and Glaucoma Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Healthy Volunteers and Glaucoma Patients
Interventions
DRUG

MRZ-99030 eye drops 5mg/mL

DRUG

MRZ-99030 eye drops 20mg/mL

DRUG

Placebo to MRZ-99030 eye drops

Trial Locations (1)

14050

Parexel International GmbH, Early Phase Clinical Unit, Berlin

Sponsors
All Listed Sponsors
lead

Merz Pharmaceuticals GmbH

INDUSTRY

NCT01714960 - Safety and Tolerability of MRZ-99030 Eye Drops in Healthy Volunteers and Glaucoma Patients | Biotech Hunter | Biotech Hunter